When the crisis began, the lines seemed endless. Around 50 people showed up outside Prime Alternative Care Center in Merrimack at 11 a.m., anxious to pick up their prescribed therapeutic cannabis as other health clinics and businesses closed.
But now that it’s become clear that New Hampshire’s five therapeutic cannabis dispensaries aren’t going anywhere, throughout the COVID-19 crisis, the surge has evened out a little.
And the facilities themselves are adapting to the new reality.
The cannabis dispensaries didn’t explicitly show up in the list of essential businesses last week and they haven’t received airtime in the governor’s press conferences.
But the clinics are still open for business, and they’re seeing more demand than ever, managers say.
“Knowing that we’re still here and not having had any significant new orders … has been helpful at just kind of calming the waters a little,” said Keenan Blum, at Prime ATC. “We are able to keep up with everyone’s need as long as everyone is patient and steady at coming through.”
Still, some dispensaries are dealing better with the new stress than others. While some have been able to retool their workflow to arrange pickup and make services virtual, others are being hit hard. [Read more at Concord Monitor]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
While marijuana became legal for adults to purchase in Montana on New Year’s Day, a key federal agency has confirmed a fact underreported in coverage of the state’s new marijuana program: It remains illegal under federal law for individuals to simultaneously possess marijuana or marijuana products and firearms, and penalties for violating that law are…
Row by row, Oklahoma Bureau of Narcotics and Dangerous Drugs agents and Garvin County deputies cut down 2,500 marijuana plants and loaded them in a dump truck for destruction during an April 2021 raid near Pauls Valley. The grow operation had a Oklahoma Medical Marijuana Authority license, but had not obtained an additional permit from…
GW Pharmaceuticals has released further details of its cannabis development pipeline. With Epidiolex approved in the US last year it is also expecting approval for Sativex where two phase 3 trials are ongoing. Work is also underway on the use of Sativex in spinal cord injury, post-traumatic stress disorder and other forms of spasticity. Further…
by Hilary Bricken, Principle at Harris Bricken Not many people get excited about revisions and updates to the very dry National Institute of Standards and Technology (“NIST”) handbooks. For example, the NIST 44 Handbook contains the “Specifications, Tolerances, and Other Technical Requirements for Weighing and Measuring Devices.” The handbooks are adopted every year at the…